124 related articles for article (PubMed ID: 15506641)
1. Expression of mRNA for membrane-type 1, 2, and 3 matrix metalloproteinases in human laryngeal cancer.
Sun YN; Li Y
Chin Med Sci J; 2004 Sep; 19(3):170-3. PubMed ID: 15506641
[TBL] [Abstract][Full Text] [Related]
2. Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors.
Nakada M; Nakamura H; Ikeda E; Fujimoto N; Yamashita J; Sato H; Seiki M; Okada Y
Am J Pathol; 1999 Feb; 154(2):417-28. PubMed ID: 10027400
[TBL] [Abstract][Full Text] [Related]
3. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human urothelial carcinomas.
Kitagawa Y; Kunimi K; Ito H; Sato H; Uchibayashi T; Okada Y; Seiki M; Namiki M
J Urol; 1998 Oct; 160(4):1540-5. PubMed ID: 9751409
[TBL] [Abstract][Full Text] [Related]
4. [Relationship of matrilysin with invasion, metastasis, and prognosis in laryngeal cancer].
Sun YN; Li Y; Xie MQ; Jin DJ; Li P
Ai Zheng; 2004 May; 23(5):589-92. PubMed ID: 15142461
[TBL] [Abstract][Full Text] [Related]
5. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas.
Ueno H; Nakamura H; Inoue M; Imai K; Noguchi M; Sato H; Seiki M; Okada Y
Cancer Res; 1997 May; 57(10):2055-60. PubMed ID: 9158005
[TBL] [Abstract][Full Text] [Related]
6. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas.
Nakamura H; Ueno H; Yamashita K; Shimada T; Yamamoto E; Noguchi M; Fujimoto N; Sato H; Seiki M; Okada Y
Cancer Res; 1999 Jan; 59(2):467-73. PubMed ID: 9927064
[TBL] [Abstract][Full Text] [Related]
7. Coordinate expression of membrane type-matrix metalloproteinases-2 and 3 (MT2-MMP and MT3-MMP) and matrix metalloproteinase-2 (MMP-2) in primary and metastatic melanoma cells.
Ohnishi Y; Tajima S; Ishibashi A
Eur J Dermatol; 2001; 11(5):420-3. PubMed ID: 11525948
[TBL] [Abstract][Full Text] [Related]
8. Correlation of tumor- and stromal-derived MT1-MMP expression with progression of human ovarian tumors in SCID mice.
Drew AF; Blick TJ; Lafleur MA; Tim EL; Robbie MJ; Rice GE; Quinn MA; Thompson EW
Gynecol Oncol; 2004 Dec; 95(3):437-48. PubMed ID: 15581944
[TBL] [Abstract][Full Text] [Related]
9. Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma.
Gilles C; Polette M; Seiki M; Birembaut P; Thompson EW
Lab Invest; 1997 May; 76(5):651-60. PubMed ID: 9166284
[TBL] [Abstract][Full Text] [Related]
10. [Significance of membrane type-1 matrix metalloproteinase expression in breast cancer].
Yao GY; Yang MT; Rong TH; He P
Ai Zheng; 2004 Nov; 23(11 Suppl):1482-6. PubMed ID: 15566663
[TBL] [Abstract][Full Text] [Related]
11. Differential expression and origin of membrane-type 1 and 2 matrix metalloproteinases (MT-MMPs) in association with MMP2 activation in injured human livers.
Théret N; Musso O; L'Helgoualc'h A; Campion JP; Clément B
Am J Pathol; 1998 Sep; 153(3):945-54. PubMed ID: 9736043
[TBL] [Abstract][Full Text] [Related]
12. Expression of membrane-type 1, 2, and 3 matrix metalloproteinases messenger RNA in ovarian carcinoma cells in serous effusions.
Davidson B; Goldberg I; Berner A; Nesland JM; Givant-Horwitz V; Bryne M; Risberg B; Kristensen GB; Tropé CG; Kopolovic J; Reich R
Am J Clin Pathol; 2001 Apr; 115(4):517-24. PubMed ID: 11293899
[TBL] [Abstract][Full Text] [Related]
13. Induction of membrane-type-1 matrix metalloproteinase by epidermal growth factor-mediated signaling in gliomas.
Van Meter TE; Broaddus WC; Rooprai HK; Pilkington GJ; Fillmore HL
Neuro Oncol; 2004 Jul; 6(3):188-99. PubMed ID: 15279711
[TBL] [Abstract][Full Text] [Related]
14. Role of MT-MMPs and MMP-2 in pancreatic cancer progression.
Ellenrieder V; Alber B; Lacher U; Hendler SF; Menke A; Boeck W; Wagner M; Wilda M; Friess H; Büchler M; Adler G; Gress TM
Int J Cancer; 2000 Jan; 85(1):14-20. PubMed ID: 10585576
[TBL] [Abstract][Full Text] [Related]
15. Membrane-type matrix metalloproteinases (MT-MMPs) in cell invasion.
Sato H; Okada Y; Seiki M
Thromb Haemost; 1997 Jul; 78(1):497-500. PubMed ID: 9198203
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma.
Imanishi Y; Fujii M; Tokumaru Y; Tomita T; Kanke M; Kanzaki J; Kameyama K; Otani Y; Sato H
Hum Pathol; 2000 Aug; 31(8):895-904. PubMed ID: 10987249
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of matrix metalloproteinases (MMPs) in breast cancer xenografts: a major induction of stromal MMP-13.
Lafleur MA; Drew AF; de Sousa EL; Blick T; Bills M; Walker EC; Williams ED; Waltham M; Thompson EW
Int J Cancer; 2005 Apr; 114(4):544-54. PubMed ID: 15551360
[TBL] [Abstract][Full Text] [Related]
18. Expression of collagenase-3 (matrix metalloproteinase-13) in human gastric cancer.
Elnemr A; Yonemura Y; Bandou E; Kinoshita K; Kawamura T; Takahashi S; Tochiori S; Endou Y; Sasaki T
Gastric Cancer; 2003; 6(1):30-8. PubMed ID: 12673424
[TBL] [Abstract][Full Text] [Related]
19. [Morphological tumor front grading and matrix metalloproteinases type I expression as a prognostic parameter of the presence of lymph node micrometastases in laryngeal carcinoma].
Lukomski M; Lewy-Trenda I; Stasikowska O; Durko M; Starska K
Otolaryngol Pol; 2007; 61(5):805-10. PubMed ID: 18552024
[TBL] [Abstract][Full Text] [Related]
20. Membrane-type-3 matrix metalloproteinase (MT3-MMP) functions as a matrix composition-dependent effector of melanoma cell invasion.
Tatti O; Arjama M; Ranki A; Weiss SJ; Keski-Oja J; Lehti K
PLoS One; 2011; 6(12):e28325. PubMed ID: 22164270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
